Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000097 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
28,937
Total Value
$1,076,185.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Vice President, Finance | Common Stock | โ | Sep 11, 2026 | Exercise/Conversion | 8,000 | $12.50 | $100,000.00 | 23,312 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Sep 11, 2026 | Exercise/Conversion | 1,459 | $34.39 | $50,175.01 | 24,771 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Sep 11, 2026 | Sale | 3,000 | $91.11 | $273,321.90 | 21,771 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Sep 11, 2026 | Sale | 4,051 | $92.41 | $374,367.09 | 17,720 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Sep 11, 2026 | Sale | 2,208 | $93.26 | $205,920.51 | 15,512 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Sep 11, 2026 | Sale | 200 | $94.02 | $18,803.00 | 15,312 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Sep 15, 2026 | Sale | 560 | $95.71 | $53,597.60 | 14,752 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Sep 11, 2026 | Exercise/Conversion | 8,000 | $0.00 | $0.00 | 84,917 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Sep 11, 2026 | Exercise/Conversion | 1,459 | $0.00 | $0.00 | 58,333 | Direct | โ | View Details |